Blog

Insights & Updates

Company news, regulatory developments, and perspectives on the future of evidence synthesis.

March 3, 2026|Industry Insight

The Regulatory Shift Toward Living Evidence

The FDA and EMA are converging on continuous, real-time evidence requirements. From the single-trial policy to DARWIN EU, here's what's changing and why it matters for evidence synthesis.

March 1, 2026|Company News

Introducing Mapped Technologies

We are physicians, researchers, and engineers who came together to build research-grade software for medical science. This is who we are and what we're building.

February 20, 2026|Industry Insight

Why Evidence Synthesis Is Broken — And What Comes Next

Systematic reviews take 30 weeks, have a 10.76% error rate, and two-thirds are never updated. With 388 AI tools and none covering the full lifecycle, the tooling problem is clear.